sobuzoxane has been researched along with Lymphoma in 3 studies
sobuzoxane: used in treatment of leukemia L1210
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
Excerpt | Relevance | Reference |
---|---|---|
" The patient achieved a complete response (CR) after treatment with oral low-dose sobuzoxane and etoposide combined with rituximab." | 5.40 | [Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma]. ( Abe, Y; Choi, I; Haji, S; Kiyasu, J; Ohshima, K; Suehiro, Y; Toyoda, K; Tsuda, M; Uike, N, 2014) |
"Sobuzoxane (MST-16) is an analogue of ICRF-159 which was once evaluated on the clinical efficacies in England." | 2.39 | [A novel antitumor agent, sobuzoxane (MST-16)]. ( Tsukagoshi, S, 1994) |
" The patient achieved a complete response (CR) after treatment with oral low-dose sobuzoxane and etoposide combined with rituximab." | 1.40 | [Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma]. ( Abe, Y; Choi, I; Haji, S; Kiyasu, J; Ohshima, K; Suehiro, Y; Toyoda, K; Tsuda, M; Uike, N, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ohmoto, A | 1 |
Fuji, S | 1 |
Toyoda, K | 1 |
Abe, Y | 1 |
Tsuda, M | 1 |
Haji, S | 1 |
Choi, I | 1 |
Suehiro, Y | 1 |
Kiyasu, J | 1 |
Ohshima, K | 1 |
Uike, N | 1 |
Tsukagoshi, S | 1 |
1 review available for sobuzoxane and Lymphoma
Article | Year |
---|---|
[A novel antitumor agent, sobuzoxane (MST-16)].
Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Humans; Leukemia, Experimental; | 1994 |
2 other studies available for sobuzoxane and Lymphoma
Article | Year |
---|---|
Clinical feasibility of oral low-dose etoposide and sobuzoxane for conventional chemotherapy-intolerant lymphoma patients.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Feasibility Studies | 2021 |
[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Herpesvirus 8, Human; Humans; Lymph | 2014 |